Provisional Side-Branch Stenting at Bifurcations Is Safe and Effective

In a large case series, the use of drug-eluting stents and a provisional T-stenting strategy resulted in good 2-year outcomes.

The treatment of bifurcation stenoses, frequently with multiple stents, is associated with lower success rates and more complications than is the treatment of simpler coronary artery lesions. In this prospective registry study, investigators at a single center in France used drug-eluting stents and a provisional side-branch T-stenting strategy to treat 477 consecutive bifurcation lesions. After kissing-balloon inflation, a stent was deployed in the side branch only if residual stenosis was >50% or TIMI flow grade was <3.

At baseline, 32% of the study population had diabetes, 68% had multivessel disease, and 9% had an LV ejection fraction <50%. A side-branch stent was deployed in 29% of procedures. The procedural success rate was 98.5%, and i…

Reviewing Author

Howard C. Herrmann, MD

Disclosures

Consultant/Advisory BoardAffluent Medical; Artedrone; Caranx; Johnson & Johnson; Medtronic; Prolifagen; Wells Fargo

EquityMicrointerventional Devices, Inc.

RoyaltiesUniversity of Pennsylvania

Grant/Research SupportAbbott Vascular; Edwards Lifesciences; Johnson & Johnson; Medtronic

Editorial BoardsCatheterization and Cardiovascular Interventions; Journal of the American College of Cardiology; Circulation: Cardiovascular Interventions; JACC Cardiovascular Interventions; JACC Case Reports; JSCAI